Skip to main content

Zolpidem for the Treatment of Catatonia

Image
By
Zolpidem, a positive allosteric modulator of gamma-aminobutyric acid receptors, seems to be a safe and effective treatment alternative. 
Martain and colleagues were the first to report a dramatic durable improvement of catatonia, resistant to electroconvulsive therapy and benzodiazepines, with zolpidem in a 56-year-old woman that was in a catatonic state secondary to a subcortical stroke. Two years later, the same group presented an open study with zolpidem in seven catatonic patients, observing remission of catatonic symptoms in five of them within 15–30 minutes after ingestion, lasting 2–5 h. They observed these therapeutic effects at a plasma concentration between 80 and 130 ng/L. 

They also published a case report about catatonia in a 21-year-old woman, resolving 15 minutes after administration of zolpidem as the plasma concentration reached a peak level of 90 ng/mL. Relapse occurred after 4 h when plasma concentrations fell below 90 ng/mL. In a subsequent publication of the same French group, the authors confirm a prompt response (i.e., reduction of at least 50% of symptoms) in all patients 20 minutes after the administration of 10 mg zolpidem, at a plasma level of 80–150 ng/L. They replicate these favorable results in seldom reports. 

Zolpidem Challenge Test

Sometimes, the beneficial response to zolpidem occurred after treatment with benzodiazepines, and/or electroconvulsive therapy had failed. These data have led to the proposition of a Zolpidem Challenge Test, and have urged some clinicians to continue treatment with zolpidem instead of benzodiazepines, using doses from 7.5 to 40 mg per day, without noticeable adverse effects. Even though the short-half life results in a transient effect on symptoms, long-term treatment with zolpidem has also been described.
Labels:

Comments

Post a Comment

Your Thoughts?

Popular posts from this blog

ADVOKATE: A Mnemonic Tool for the Assessment of Eyewitness Evidence

By
ADVOKATE: A Mnemonic Tool for Assessment of Eyewitness Evidence A tool for assessing eyewitness  ADVOKATE is a tool designed to assess eyewitness evidence and how much it is reliable. It requires the user to respond to several statements/questions. Forensic psychologists, police or investigative officer can do it. The mnemonic ADVOKATE stands for: A = amount of time under observation (event and act) D = distance from suspect V = visibility (night-day, lighting) O = obstruction to the view of the witness K = known or seen before when and where (suspect) A = any special reason for remembering the subject T = time-lapse (how long has it been since witness saw suspect) E = error or material discrepancy between the description given first or any subsequent accounts by a witness.  Working with suspects (college.police.uk)
Post a Comment
Read more

ICD-11 Criteria for Attention Deficit Hyperactivity Disorder (ADHD) 6A05

By
ICD-11 Criteria for Attention Deficit Hyperactivity Disorder (ADHD) 6A05 Attention deficit hyperactivity disorder is characterised by a persistent pattern (at least 6 months) of inattention and/or hyperactivity-impulsivity that has a direct negative impact on academic, occupational, or social functioning. There is evidence of significant inattention and/or hyperactivity-impulsivity symptoms prior to age 12, typically by early to mid-childhood, though some individuals may first come to clinical attention later. The degree of inattention and hyperactivity-impulsivity is outside the limits of normal variation expected for age and level of intellectual functioning. Inattention refers to significant difficulty in sustaining attention to tasks that do not provide a high level of stimulation or frequent rewards, distractibility and problems with organisation. Hyperactivity refers to excessive motor activity and difficulties with remaining still, most evident in structured situations that re...
Post a Comment
Read more

ICD-11 Criteria for Depression (Recurrent Depressive Disorder) 6A71

By
ICD-11 Criteria for Depression (Recurrent Depressive Disorder) 6A71 Recurrent depressive disorder is characterised by a history or at least two depressive episodes separated by at least several months without significant mood disturbance. A depressive episode is characterised by a period of depressed mood or diminished interest in activities occurring most of the day, nearly every day during a period lasting at least two weeks accompanied by other symptoms such as difficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, psychomotor agitation or retardation, and reduced energy or fatigue. There have never been any prior manic, hypomanic, or mixed episodes, which would indicate the presence of a Bipolar disorder. Inclusions:                Seasonal depressive disorder Exclusions:    ...
Post a Comment
Read more